12 July

DG Trade State of Play reveals EU's ambitions for IP protection in FTAs

20 May

Statement on conflicts of interest delivered at WHA on behalf of HAI, Berne Declaration, KEI, TWN, PHM, IBFAN

17 May

Conflicts of Interest and the Future of Financing for WHO.

10 May

DG Trade public hearing on the “Protection and enforcement of IPR in third countries

29 April

EU-Mercosur Trade Negotiations: What Fate for Access to medicines?

29 April

Foundations: Conlicts of interests and Democracy issues

25 February

European drug regulator challenged over revolving door case involving former Director

1 February

Corporate funding linked to EU patient & consumer groups policy

20 December

EMA reviews transparency criteria

1 December

HAI research on financial disclosure featured in article: European politicians' call for greater transparency

25 October

ACTA, Democracy & Access to Medicines

22 October

Selling Sickness through unbranded disease awareness campaigns?

22 October

HAI Europe Statement: EMA talks the ‘conflicts of interest’ talk, but will it walk the walk?

22 October

Systematic review of drug promotion's influence on prescribing

18 October

Doha Declaration Par 6 to be reviewed in TRIPS Council

6 October

Welfare Implications of Intellectual Property Enforcement

23 September

Dutch Minister of Health supports HAI E's financial transparency recommendations to EMA

2 September

Report exposes how Big Pharma has hijacked EU-India trade deal

30 August

In perspective: EMA comments on HAI Europe's survey of financial disclosure

25 August

Impact of HAI Europe survey results: Two weeks on

11 August

HAI Europe survey reveals new data on financial transparency of patient and consumer organisations

14 July

Open Health Forum: more room for civil society?

29 June

Priorities of the Belgian Presidency

28 June

HAI Europe recommendations for improved conflict of interest declarations at EMA

24 June

International Experts Find that Pending Anti-Counterfeiting Trade Agreement Threatens Public Interests

23 June

ISDB & MiEF criticize EMA over conflict of interest procedures

14 June

Innovation & Access at the EU High Level Event on Global Health

14 June

Review of conflict of interest policies in three European medicines regulation agencies

3 June

Quito Declaration

1 June

Independent drug bulletin and assessment reports from Spain – now in English